Abstract
New Zealand drug prices will rise and cheap generic medicines will be marginalised if a proposed law setting up the Trans-Tasman Regulation of Medicines goes through Parliament. A controversial bill now before the House aims to create a single Australia-New Zealand safety regulator for medicines.
| Original language | English |
|---|---|
| Pages | 1 |
| No. | 8 May, 2007 |
| Specialist publication | New Zealand Herald |
| Publication status | Published - 2007 |